MAPK3 and hepatocellular carcinoma: While the published study demonstrated that Erk1/2 is correlated with SSPH I‐induced ROS elevation and autophagy inhibition in HCC cells, it crucially omitted investigation of the regulatory interplay between Erk1/2 and ROS in ferroptosis induction and failed to address the therapeutic implications of this mechanism for SSPH I's anti‐HCC efficacy [17].